Evidence map›Paper›PMID 24316422›Full record

ArticleMicrovascular research2014

Objective area measurement technique for choroidal neovascularization from fluorescein angiography.

Micah J Guthrie, Christian R Osswald, Nicole L Valio, William F Mieler, Jennifer J Kang-Mieler

Open access · greenAbstract read
In one paragraph

Article in Microvascular research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.Journal of the American Heart Association · 2019
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Micah J GuthrieDepartment of Biomedical Engineering, Illinois Institute of Technology, 3255 South Dearborn Street, Wishnick Hall Room 314, Chicago, IL 60616, USA.
Christian R OsswaldDepartment of Biomedical Engineering, Illinois Institute of Technology, 3255 South Dearborn Street, Wishnick Hall Room 314, Chicago, IL 60616, USA.
Nicole L ValioDepartment of Biological and Chemical Sciences, Illinois Institute of Technology, Chicago, IL 60616, USA.
William F MielerDepartment of Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.
Jennifer J Kang-MielerDepartment of Biomedical Engineering, Illinois Institute of Technology, 3255 South Dearborn Street, Wishnick Hall Room 314, Chicago, IL 60616, USA. Electronic address: kang-mieler@iit.edu.
Illinois Institute of Technology · USUniversity of Illinois Chicago · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Biocompatibility of thermo-responsive hydrogel ocular drug delivery systemR15EY020807 · NEI · ILLINOIS INSTITUTE OF TECHNOLOGY · PI KANG-MIELER, JENNIFER J · 2010 to 2010
$361k
NCI NIH HHS CA060553NCI NIH HHS P30 CA060553NEI NIH HHS EY020807-01NEI NIH HHS R15 EY020807
6 · The paper itself

Abstract

The purpose of this study was to develop a non-biased method of quantitatively measuring choroidal neovascularization (CNV) areas based on late-phase fluorescein angiography (FA) images. Experimental CNV was induced in Long Evans rats by laser disruption of the Bruch's membrane. FA was performed weekly for 5weeks. Multi-Otsu thresholding (MOT) was used to quantify CNV in late-phase FA images from both experimental rodent CNV and wet age-related macular degeneration (wAMD) patients. Images were automatically thresholded into three levels based on the image histogram, with the highest level containing CNV. To determine the technique's ability to quantify CNV areas, rats were given either triamcinolone acetonide or dexamethasone sodium phosphate to treat CNV and compared to untreated rats. The rat CNV lesion areas measured from 5-week histology sections from each treatment group were compared to areas measured from the corresponding FA images. MOT was able to detect statistical decreases in rodent CNV area in the treatment groups versus control from weeks 3 through 5. The ratio of CNV area measured from histology to area measured from FA images was not statistically different between groups. Finally, to determine the usefulness of MOT on pathological morphologies of CNV, MOT was performed on late-phase FA images from patients with classic and diffuse CNV. The technique was able to segment classical CNV in wAMD patients, but performed poorly with diffuse CNV. MOT provides a robust, objective, and quantifiable area measurement of CNV lesion area in both experimentally-induced and pathological CNV. The results indicate that MOT could be a useful research tool in helping evaluate the effects of therapeutics on CNV growth.

Indexed as

AnimalsBruch MembraneChoroidal NeovascularizationDexamethasoneFluoresceinFluorescein AngiographyHumansHydrogelsImage Processing, Computer-AssistedIntravitreal InjectionsLasersMacular DegenerationMaleNanospheresRatsRats, Long-EvansDexamethasonedexamethasone 21-phosphateFluoresceinHydrogelsTriamcinolone Acetonide

Identifiers

PMID24316422
PMCPMC3946980
OpenAlexW2033689453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.